Tag: Pharma acquisition news
Cullinan Oncology to sell Cullinan Pearl to Taiho Pharmaceutical for $275m
American biopharma company Cullinan Oncology has agreed to sell its subsidiary Cullinan Pearl to Taiho Pharmaceutical, a Japanese specialty pharma company, for $275 million. Cullinan ... Read More
Pfizer to acquire Biohaven in $11.6bn deal to gain access to rimegepant
Pfizer has agreed to acquire Biohaven Pharmaceutical, a US-based biopharma company, in a deal worth around $11.6 billion, to gain access to the latter’s dual-acting ... Read More
GSK to acquire US biopharma company Sierra Oncology for $1.9bn
GlaxoSmithKline (GSK) has agreed to acquire Sierra Oncology, a California-based biopharma company, in a deal worth around $1.9 billion (£1.5 billion). As per the terms ... Read More
Axsome Therapeutics to acquire Sunosi from Jazz Pharmaceuticals
Axsome Therapeutics has agreed to acquire Sunosi (solriamfetol), an approved dual-acting dopamine and norepinephrine reuptake inhibitor (DNRI), from Jazz Pharmaceuticals. Sunosi is indicated to improve ... Read More
Equillium acquires Bioniz Therapeutics to expand immunomodulatory drug pipeline
Equillium, a Nasdaq-listed biotech company, has acquired Bioniz Therapeutics in a deal worth up to around $329 million, in a move to considerably expand its ... Read More
Dr. Reddy’s to acquire German medical cannabis firm Nimbus Health
Dr. Reddy’s Laboratories has agreed to acquire Nimbus Health, a German medical cannabis firm, for an undisclosed price. The Indian pharma company will acquire Nimbus ... Read More
JBCPL to buy certain probiotic and reproductive health brands from Sanzyme
J.B. Chemicals & Pharmaceuticals (JBCPL) has agreed to acquire certain probiotic brands and infertility and hormone products for the Indian market from Sanzyme in a ... Read More
Merck to acquire US biopharma CDMO Exelead for $780m
Pharma giant Merck has signed an all-cash deal worth around $780 million to acquire Exelead, an Indiana-based biopharmaceutical contract development and manufacturing organization (biopharma CDMO). ... Read More
Novartis to acquire ocular gene therapy company Gyroscope Therapeutics
Novartis has agreed to acquire Gyroscope Therapeutics, a UK-based ocular gene therapy company, in a deal worth up to $1.5 billion. As per the terms ... Read More
Pfizer to acquire US biopharma company Arena Pharmaceuticals for $6.7bn
Pfizer has agreed to acquire Arena Pharmaceuticals, a publicly-listed clinical stage biopharma company based in the US, for about $6.7 billion. As per the terms ... Read More
